Similar articles

• [Alcoholic and non-alcoholic steatohepatitis].

  Dufour JF, Oneta CM. Dufour JF, et al. Ther Umsch. 2004 Aug;61(8):505-12. doi: 10.1024/0040-5930.61.8.505. Ther Umsch. 2004. PMID: 15457967 Review. German.
• Pharmacologic therapy of non-alcoholic steatohepatitis.

  Ratziu V, Zelber-Sagi S. Ratziu V, et al. Clin Liver Dis. 2009 Nov;13(4):667-88. doi: 10.1016/j.cld.2009.07.001. Clin Liver Dis. 2009. PMID: 19818312
• [Fatty liver: frequent and not completely harmless].

  Lang C, Georgi A, Gubler C. Lang C, et al. Praxis (Bern 1994). 2013 Sep 4;102(18):1089-101. doi: 10.1024/1661-8157/a001420. Praxis (Bern 1994). 2013. PMID: 24005067 German. No abstract available.
• [Fatty liver].

  Andrade RJ, García-Escaño MD. Andrade RJ, et al. Med Clin (Barc). 2000 Apr 22;114(15):574-6. doi: 10.1016/s0025-7753(00)71367-4. Med Clin (Barc). 2000. PMID: 10846676 Spanish. No abstract available.
• Review article: Drug therapy for non-alcoholic fatty liver disease.

  Comar KM, Sterling RK. Comar KM, et al. Aliment Pharmacol Ther. 2006 Jan 15;23(2):207-15. doi: 10.1111/j.1365-2036.2006.02751.x. Aliment Pharmacol Ther. 2006. PMID: 16393299 Review.